Trimax Pharmaceuticals Pvt Ltd - Company Profile

It is a chemicals private limited company based in Mohali, Punjab, India, established in 1992.
1992 Mohali, Punjab, India Struck Off
Last Updated:
Access Report
About Trimax Pharmaceuticals Pvt Ltd

Trimax Pharmaceuticals Pvt Ltd, a struck off private limited company, was established on 03 July 1992 in Mohali, Punjab, India. Engaging in medicinal chemical & botanical products within the chemicals sector, it holds CIN: U24232PB1992PTC012445. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.47 M.

Its leadership includes Gurbachan Kaur (Director), Rakesh Kumar Malhotra (Director). Its latest AGM occurred on 30 September 2015, with the balance sheet filed on 31 March 2015. It is based at E 126Industrial Area Phase Vill Sas Nagar, Mohali, Punjab, 160055.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232PB1992PTC012445

  • Registration Number

    012445

  • Incorporation Date

    03 July 1992

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.47 M

  • ROC Code

    Roc Chandigarh

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.47 M
  • Company Age 33 Year, 7 Months
  • Last Filing with ROC 31 Mar 2015
Company report

Trimax Pharmaceuticals Pvt Ltd

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Trimax Pharmaceuticals Pvt Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Trimax Pharmaceuticals Pvt Ltd?
Current Directors
Name Designation Appointment Date Status
Gurbachan Kaur Director 07 Nov 1995 Current
Rakesh Kumar Malhotra Director 24 Jan 2007 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Trimax Pharmaceuticals.

Enhance accessibility to Trimax Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Trimax Pharmaceuticals revenue growth over time
Trimax Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Trimax Pharmaceuticals?

Unlock access to Trimax Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Trimax Pharmaceuticals?

Unlock and access historical data on people associated with Trimax Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Trimax Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Trimax Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Trimax Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    The activity Trimax Pharmaceuticals Pvt Ltd last Annual general meeting of members was held on 30 Sep 2015 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Trimax Pharmaceuticals Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2015 with Roc Chandigarh. was documented.

  • Director Appointment

    Progress on Rakesh Kumar Malhotra was appointed as a Director was appointed as a Director on 24 Jan 2007 & has been associated with this company since 19 years 17 days . was documented.

  • Director Appointment

    Progress on Gurbachan Kaur was appointed as a Director was appointed as a Director on 07 Nov 1995 & has been associated with this company since 30 years 3 months . was documented.

  • Company Incorporation

    The activity Trimax Pharmaceuticals Pvt Ltd was registered on 03 Jul 1992 with Roc Chandigarh & aged 33 years 7 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Trimax Pharmaceuticals Pvt Ltd?

The CIN of Trimax Pharmaceuticals Pvt Ltd is U24232PB1992PTC012445.

Where is Trimax Pharmaceuticals Pvt Ltd headquartered?

Trimax Pharmaceuticals Pvt Ltd is headquartered at E 126Industrial Area Phase Vill Sas Nagar, Mohali, Punjab, 160055.

When was Trimax Pharmaceuticals Pvt Ltd incorporated?

Trimax Pharmaceuticals Pvt Ltd was incorporated on 03 July 1992.

Who are the current directors of Trimax Pharmaceuticals Pvt Ltd?

The current directors of Trimax Pharmaceuticals Pvt Ltd are

What is the primary industry of Trimax Pharmaceuticals Pvt Ltd?

The primary industry of Trimax Pharmaceuticals Pvt Ltd is Chemicals.

Is Trimax Pharmaceuticals Pvt Ltd a listed company?

Trimax Pharmaceuticals Pvt Ltd is unlisted.

What is the capital structure of Trimax Pharmaceuticals Pvt Ltd?

The authorized capital of Trimax Pharmaceuticals Pvt Ltd is ₹0.50 M, and the paid-up capital is ₹0.47 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available